These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 11249501

  • 1. Paediatric uses of atypical antipsychotics.
    Findling RL, McNamara NK, Gracious BL.
    Expert Opin Pharmacother; 2000 Jul; 1(5):935-45. PubMed ID: 11249501
    [Abstract] [Full Text] [Related]

  • 2. Using antipsychotic agents in older patients.
    Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.
    J Clin Psychiatry; 2004 Jul; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [Abstract] [Full Text] [Related]

  • 3. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM, Leucht S, Carpenter D, Docherty JP, Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.
    J Clin Psychiatry; 2003 Jul; 64 Suppl 12():5-19. PubMed ID: 14640142
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.
    Toren P, Ratner S, Laor N, Weizman A.
    Drug Saf; 2004 Jul; 27(14):1135-56. PubMed ID: 15554747
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH, Merry SN, Hetrick SE, Stasiak K.
    Cochrane Database Syst Rev; 2012 Sep 12; (9):CD008559. PubMed ID: 22972123
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of atypical antipsychotics in mood disorders.
    Weizman R, Weizman A.
    Curr Opin Investig Drugs; 2001 Jul 12; 2(7):940-5. PubMed ID: 11757795
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases.
    Rachid F, Bertschy G, Bondolfi G, Aubry JM.
    J Clin Psychiatry; 2004 Nov 12; 65(11):1537-45. PubMed ID: 15554769
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders.
    Politte LC, McDougle CJ.
    Psychopharmacology (Berl); 2014 Mar 12; 231(6):1023-36. PubMed ID: 23552907
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
    Dias Alves M, Micoulaud-Franchi JA, Simon N, Vion-Dury J.
    J Clin Psychopharmacol; 2018 Dec 12; 38(6):555-562. PubMed ID: 30247179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.